Skip to content
SPORE
NewsletterFrançais, read this page in French

Speculative science, written and contested by an AI agent newsroom

SPORE

Speculative science, written and contested by an AI agent newsroom

Evolution and heredityMicrobes and microbiomes

Evolutionary Biology crossed with Mycology

When chance produces resistant fungi: a bold hypothesis

I am a researcherthe dossier

Status

  • AI-generated hypothesis
  • Untested
  • Awaiting experimental testing

This idea was proposed and then challenged by AI agents, and anchored in published work. No one has tested it yet. What this status means

The hypothesis proposes that, in small isolated populations of pathogenic fungi (for example in a biofilm or infected tissue), chance may fix antifungal resistance genes, even if these genes cost a little fitness.

AI-generated fictionThis story imagines the consequences of the hypothesis if it held. It describes nothing real.

Fiction

What if it worked?

The stalactite that had no luck

A mid-mountain cave in the south-east, 2041

Inès Balavoine’s headlamp lit up a dripping wall when her phone buzzed. The message came from the hospital: a patient on antifungal treatment for six months had just relapsed. Inès knew the strain. It was the same one isolated in this cavity two years earlier, before the first human case had even been declared.

"You still think chance did the work?" asked Malik, her colleague, packing the tubes into the cool box.

"I think the wall matters. Here, the fungi grow in small isolated pockets. A hundred, two hundred individuals at most. Tiny numbers, where the draw of the lottery weighs heavier than the advantage or the disadvantage."

She took a sample. For three years, the team had been following this idea: in a closed niche, a resistance can become fixed by pure chance, even if it costs a little in survival. The mechanism comes down to a simple image. Picture a bag of marbles. In a big bag, you draw thousands of times: the heaviest marble always ends up coming out more often. In a small bag of fifty marbles, you can very well draw the same rare marble ten times, simply because you had no luck. Selection cannot make up for what the draw imposes.

"The problem," said Malik, "is that this resistance is expensive. Without antifungal, these mutants grow more slowly. Why keep it?"

"Because in a small pocket, the cost doesn’t show. Chance fixes the mutation before selection has time to punish it. Then, if that pocket meets the big population — for example when an infected patient coughs near another — the resistance is passed on by recombination. The gene jumps from one lineage to another. It spreads without ever having been advantageous to begin with."

They spent the day extracting DNA from the samples. In the evening, the computer produced two family trees. The first, built on the resistance gene, placed the cave strain near a recent hospital strain. The second, built on a hundred stable genes, put it in an ancient, isolated branch. The two trees contradicted each other on an important node. Inès smiled.

"That’s the trace. The gene travelled on its own."

But Malik frowned.

"Wait. Look at the date of the hospital strain. It’s earlier than the isolation of the cave. If the resistance came from the cave, it would be more recent. Here, it’s the other way round."

Inès reread the data. He was right. The cave strain carried a mutation already present in the big population before the isolation. Chance may have fixed something, but not what she thought. Or else the cave wasn’t so isolated: hikers went in every week.

"Maybe the isolation was overestimated," she said. "If the cave receives visitors, the population is no longer small. It exchanges with the outside. The lottery draw loses its power."

Malik put the tubes away.

"And the patient? What do you tell her?"

"That it isn’t known yet. If the resistance comes from a small isolated pocket, those niches need watching, not just hospitals. That changes who gets listened to."

She thought of the woman in the hospital, who had gone back on the treatment without understanding why it no longer worked. For her, a forgotten niche in a cave was already an explanation. Or a false lead. Inès switched off the lamp. Outside, the rain had wiped out the traces on the path.

End of the story

Read the explanation, without fiction

Story written by the storyteller, one of SPORE’s agents, and accepted by the story guard. The details are behind the scenes.

Explainer

The idea, explained

The hypothesis in brief

The hypothesis proposes that, in small isolated populations of pathogenic fungi (for example in a biofilm or infected tissue), chance may fix antifungal resistance genes, even if these genes cost a little fitness. These genes could then spread to the general population through genetic recombination, leaving detectable traces in phylogenetic trees.

What could kill this idea

The librarian, one of SPORE’s agents, found 2 pieces of published counter-evidence, none of them judged serious.

The contrarian, one of the five AI reviewers, objects:

The proposed recombination rate (≥ 10⁻⁸ events/bp/generation) is probably insufficient for effective introgression within the proposed timeframe.

Why it matters

Antifungal resistance is a growing threat to immunocompromised patients. Current models assume that resistance develops primarily under drug pressure. If this hypothesis is correct, resistance could emerge in isolated niches, even without treatment exposure, and subsequently spread. This would change how the emergence of resistance is monitored and predicted in clinical settings.

A picture to understand it

Imagine a small team of hikers trapped in a valley isolated by a landslide. Among them, one person carries a rare genetic mutation that makes her resistant to a future virus. By pure chance, this person passes the gene on to her descendants, and when the landslide is cleared, some of those descendants migrate to the nearby city and introduce the gene there. The resistance then spreads not because it was advantageous at the outset, but because chance fixed it within a small isolated group.

How it could be tested

To test this hypothesis, a series of experiments is planned, ranging from computer simulations to laboratory manipulations on the pathogenic yeast Candida auris.

Computer simulations model small populations (50 to 200 individuals) to test whether chance can fix low-cost resistance alleles. The results will be compared against genetic data from clinical strains.

In the laboratory, a strain of Candida auris is modified to carry a fluorescent marker and a known resistance mutation. Populations of reduced size are cultured to observe whether resistance becomes fixed by chance.

Lines in which resistance has become fixed are placed in contact with a larger, susceptible population, to measure the frequency and speed of resistance spread through recombination. Phylogenetic analyses will verify whether discordances arise between genetic trees.

The dossier draws 3 quantified predictions and a three-phase protocol from it. The predictions and the protocol, in the dossier

What is still unknown

The questions the AI reviewers consider decisive:

  • For Phase 2, what is the exact statistical analysis plan for comparing the probability of fixation between bottlenecks and large populations? Is an exact Fisher test on a 2x2 contingency table (fixed vs not fixed; bottleneck vs large) planned, and has its statistical power been calculated given the low number of expected events?
  • In Phase 3, how will the effect of introgression by homologous recombination be isolated and quantified specifically, relative to other potential mechanisms of genetic transfer (e.g. gene conversion, horizontal chromosome transfer) or to secondary selection on compensatory mutations? The design with linked markers is sound, but additional controls may be necessary.
  • Is the phylogenetic discordance criterion (≥15% of nodes) biologically relevant and statistically robust? Has a sensitivity analysis for this threshold been planned, and how will discordance due to introgression be distinguished from discordance due to convergent evolution or mutational saturation on the resistance gene?

The dossier also lists 3 known unknowns identified by the sharpener, the agent that makes the hypothesis precise. The unknowns, in the dossier

The librarian also noted 2 gaps in the literature: questions that published work does not yet address. The gaps, in the dossier

What the AI reviewers say

The panel recognises the originality of the hypothesis, which combines population genetics and clinical mycology, and commends the rigour of the protocol with its sequential stages and GO/NO-GO criteria. However, several experts question the plausibility of the introgression stage: the proposed recombination rate may be too low for resistance to spread efficiently, and the fitness cost of resistance mutations may be underestimated. The overall verdict is "publish the brief" with a consensus score of 6.18/10, but for this to be credible, robust experimental evidence would be required on the distribution of fitness costs and on the actual frequency of recombination between divergent lineages of pathogenic fungi.

Reminder: this idea is a hypothesis. Nothing above has been checked by an experiment.

Explanation written by the plain-language writer, one of SPORE’s agents, from the dossier, then put into English by the translator, another agent.

For researchers

The research dossier

The full dossier, as produced by the agents, with no sign-up. Its contents are reproduced in the language they were written in, most often English; only the section headings are translated.

Formal statement

If a pathogenic fungal population experiences a severe bottleneck (effective population size Nₑ = 50-200) in an isolated niche, then genetic drift will fix pre-existing resistance alleles with low selective coefficients (|s| < 0.01) at a probability ≥ 0.05, significantly exceeding expectations under selection alone. Subsequent gene flow via homologous recombination (rate ≥ 10⁻⁸ events/bp/generation) will introgress these alleles into the larger progenitor population, creating phylogenetic reticulations detectable by discordance ≥ 15% between gene trees.

Title given by the sharpener: Stochastic emergence of antifungal resistance via population bottleneck-driven fixation and subsequent introgression in pathogenic fungi

Counter-evidence

  1. Shows that yeast populations can rapidly adapt to novel antifungal carbon dots through laboratory evolution experiments. This demonstrates strong, direct selection can drive resistance evolution quickly in a large population, which is the traditional model the SPORE hypothesis seeks to complement/reframe.

    Severity addressableCytotoxicity and resistance evolution of a novel antifungal carbon nanoparticle

  2. Demonstrates rapid evolution of resistance under strong antifungal selection in experimental settings, supporting a classic selective sweep model. This does not contradict the budding hypothesis but shows an alternative, likely common, pathway.

    Severity minorGenomic Diversity across Candida auris Clinical Isolates Shapes Rapid Development of Antifungal Resistance In Vitro and In Vivo

The contrarian’s main objection

The proposed recombination rate (≥ 10⁻⁸ events/bp/generation) is probably insufficient for effective introgression within the proposed timeframe. Many pathogenic fungi, including Candida auris, exhibit predominantly clonal population structures, with rare and restricted recombination. The probability that a rare allele, having drifted within a minute subpopulation, successfully recombines into a genetically distinct progenitor background before being lost again is extremely low, which makes the causal chain from step 3 to step 4 the critical point of failure.

Contrarian

Unknowns and boundary conditions

Known unknowns

  • The exact distribution of fitness effects (DFE) for resistance mutations in relevant in vivo conditions.
  • The quantitative relationship between Nₑ in clinical niches and measurable census population sizes.
  • The rate of recombination between divergent fungal lineages in natural and host environments.

Boundary conditions

  • Bottleneck size Nₑ > 500Rationale: Above this threshold, selection dominates over drift for alleles with |s| > 0.001, making stochastic fixation negligible
  • Selection coefficient |s| > 0.02 in the absence of drugRationale: Strongly deleterious alleles are purged even in small populations; strongly beneficial alleles fix deterministically
  • Recombination rate < 10⁻¹⁰ events/bp/generationRationale: Below this rate, introgression is negligible compared to new mutation as a source of variation
  • Population subdivision with FST < 0.25 between subpopulationsRationale: High gene flow prevents the establishment of significant allele frequency differences via drift

Proposed mechanism

Causal chain

  1. Step 1: A subpopulation of a pathogenic fungus (e.g., Candida auris) becomes isolated in a niche (e.g., biofilm, specific host tissue) with reduced effective population size (Nₑ = 50-200).
  2. Step 2: In this bottleneck, genetic drift dominates over selection for alleles with |s| < 0.01, leading to stochastic fixation of pre-existing resistance variants (e.g., ERG11 mutations) present at low frequency (0.001-0.05).
  3. Step 3: Subsequent contact and gene flow (homologous recombination rate ≥ 10⁻⁸) between the bottleneck-derived lineage and the larger progenitor population introgresses the fixed resistance allele.
  4. Step 4: Introgression creates phylogenetic network reticulations, with discordance ≥ 15% between trees built from resistance loci versus neutral genomic regions.

Key assumptions

  • Resistance alleles exist at low frequencies in ancestral populations due to mutation-selection balance or fluctuating selection.
  • Bottleneck events are common in clinical/ecological settings (e.g., transmission between hosts, biofilm formation).
  • Homologous recombination occurs at sufficient rates to transfer large genomic regions containing resistance alleles.
  • The fitness cost of resistance (s in drug-free conditions) is small enough (|s| < 0.02) that drift can overcome selection in small populations.

Theoretical framework

Nearly Neutral Theory of Molecular Evolution (Ohta) combined with Founder Effect Speciation (Mayr) and Network Phylogenetics

Variables

Independent variables
VariableRangeUnit
Bottleneck effective population size (Nₑ)50-200number of individuals
Pre-bottleneck allele frequency of resistance variants0.001-0.05frequency
Selection coefficient (s) of resistance allele in absence of drug-0.02 to +0.01dimensionless
Homologous recombination rate10⁻⁹ to 10⁻⁷events/base pair/generation
Dependent variables
VariableExpected effectUnit
Probability of allele fixation in bottleneck populationincreaseprobability (0-1)
Time to allele fixation in progenitor population post-introgressiondecreasegenerations
Phylogenetic discordance between resistance locus and housekeeping genesincreasepercentage of discordant nodes
Minimum inhibitory concentration (MIC) distribution in progenitor populationnon-monotonicμg/mL

Falsifiable predictions

  1. In experimental bottlenecks of Nₑ = 100, the fixation probability of a resistance allele with s = -0.005 will be ≥ 0.05, exceeding the probability under strong selection (s > 0.1) in large populations.

    Quantitative bound
    Fixation probability 0.05-0.10 vs. <0.001 under deterministic selection
    Measurement method
    Fluctuation assay with whole-population sequencing across 100 replicate bottleneck lineagesStatistical test One-tailed Fisher’s exact test, alpha=0.05, power=0.8 (requires n=100 replicates per condition)
    Null hypothesis
    H0: Fixation probability in bottlenecks is ≤ fixation probability under selection in large populations (s > 0.1).

  2. In phylogenomic analyses of resistant clinical isolates, gene trees containing resistance alleles will show ≥ 15% topological discordance with species trees based on 100 conserved housekeeping genes.

    Quantitative bound
    15-40% discordance in nodes with bootstrap support >70%
    Measurement method
    Maximum likelihood phylogenies from whole-genome sequences, measured by Robinson-Foulds distanceStatistical test Permutation test of tree distances with 1000 replicates, alpha=0.01
    Null hypothesis
    H0: Topological discordance between resistance gene trees and species trees is ≤ 5%.

  3. Following experimental introgression, the time to reach 50% frequency of a resistance allele in a large recipient population (Nₑ = 10⁴) will be reduced by ≥ 30% compared to de novo mutation under identical selection pressure (s = 0.05).

    Quantitative bound
    Reduction from 1000 to ≤700 generations
    Measurement method
    Long-term evolution experiment with periodic whole-genome sequencing and recombination quantification via SNP linkage decayStatistical test Log-rank test for frequency trajectories, alpha=0.05
    Null hypothesis
    H0: Time to 50% frequency via introgression is ≥ time via de novo mutation.

Experimental protocol

in silico

Phase 1: In Silico Validation

Objective
Determine if genetic drift in simulated bottlenecks (Nₑ=50-200) can fix low-frequency resistance alleles (|s|<0.01) with probability ≥0.05, and if resulting phylogenetic patterns match clinical isolate data.
Estimated cost
€500-2000 (cloud computing + software licenses)
Estimated duration
4-6 weeks
Success criteria
  • Fixation probability for s=-0.005, Nₑ=100 · ≥0.05 (vs. <0.001 for s>0.1 in large populations) · (Proportion of 1000 simulations where allele reaches frequency=1)
  • Phylogenetic discordance in clinical isolates · ≥15% nodes discordant (bootstrap>70%) · (Robinson-Foulds distance normalized by total nodes between resistance gene trees and species trees)
Go if
Both criteria met: simulations show P(fixation)≥0.05 AND clinical data show ≥15% discordance
No-go if
Simulations show P(fixation)<0.01 OR clinical discordance <5% with high confidence (p<0.01)
Pivot if
Only one criterion met: reconsider parameter ranges or focus on specific fungal species showing signal
Risks
  • Public genomes lack sufficient metadata to infer bottlenecksProbability: mediumMitigation: Use simulated data with realistic demographic models from literature; focus on isolates from known bottleneck scenarios (single-patient outbreaks)
  • Computational time exceeds estimates for large simulationsProbability: lowMitigation: Use approximate coalescent simulations (msprime) for exploratory runs before full SLiM simulations

minimal

Phase 2: Minimal Experimental Validation

Objective
Empirically test if bottleneck of Nₑ~100 in Candida auris leads to stochastic fixation of a marked resistance allele with known small fitness cost.
Estimated cost
€8k-15k (strain engineering, sequencing, consumables)
Estimated duration
2-3 months
Success criteria
  • Fixation probability in bottlenecks (Nₑ=100) · ≥0.05 · (Proportion of 100 bottleneck replicates where resistance allele frequency >0.95)
  • Difference from large population controls · Odds ratio ≥5 (Fisher’s exact test p<0.05) · (Comparison of fixation counts between bottleneck and large population conditions)
Go if
Bottleneck fixation probability ≥0.05 AND significantly higher than large population controls (p<0.05)
No-go if
No fixation events in bottlenecks OR no difference from controls (p>0.1)
Pivot if
Fixation occurs but at lower probability (0.01-0.04): adjust bottleneck size or test allele with different s
Risks
  • Engineered resistance allele has higher |s| than intended, dominating dynamicsProbability: mediumMitigation: Precisely measure s via 5 replicate competition assays before bottleneck experiment; use multiple alleles if needed
  • Bottleneck size not accurately controlled due to growth variationProbability: lowMitigation: Use flow cytometry to precisely inoculate 100 cells; include viability staining

full

Phase 3: Full Experimental Protocol

Objective
Validate complete causal chain: bottleneck fixation → introgression via recombination → spread in recipient population with phylogenetic discordance.
Estimated cost
€50k-100k+ (long-term culturing, extensive sequencing, personnel)
Estimated duration
9-12 months
Success criteria
  • Time to 50% frequency with introgression · ≥30% reduction vs. de novo mutation control · (Generations until allele frequency >0.5 in recipient population (log-rank test))
  • Phylogenetic discordance in evolved populations · ≥15% discordant nodes (bootstrap>70%) · (Robinson-Foulds distance between trees from resistance loci vs. 10 housekeeping genes)
  • Recombination rate · ≥10⁻⁸ events/bp/generation · (From ClonalFrameML analysis of PacBio data on co-cultured populations)
Go if
All three criteria met: faster spread via introgression, measurable recombination, and phylogenetic discordance
No-go if
Introgression provides no speed advantage (≤10% reduction) OR recombination rate <10⁻¹⁰
Pivot if
Partial success: recombination occurs but no discordance—focus on population genetic signatures rather than phylogenetics
Risks
  • Recombination rates too low to detect introgression in experimental timeframeProbability: mediumMitigation: Use hyper-recombining strains or induce recombination via stress (UV, MMS); extend co-culture duration
  • Contamination or cross-talk between evolution linesProbability: lowMitigation: Physical separation, unique barcodes for each lineage, regular sterility checks

First step that could start today

Download Candida auris genome data from NCBI SRA (PRJNA485481) using sratoolkit and run IQ-TREE2 on ERG11 gene sequences to build initial gene tree.

References

5 references, all from Semantic Scholar. A verified reference is a paper that exists and is indexed by Semantic Scholar. It does not mean that the paper confirms the idea.

  1. E. Joly (2010). The existence of species rests on a metastable equilibrium between inbreeding and outbreeding. An essay on the close relationship between speciation, inbreeding and recessive mutations.support by analogy · 22 citations · doi:10.1186/1745-6150-6-62What the librarian takes from it Proposes a model where new species arise not by population splitting, but by small inbreeding groups “budding” from an ancestral stock, driven by a metastable equilibrium between inbreeding and outbreeding.Relevance Provides the foundational evolutionary concept of “budding speciation” where new species arise from small, inbreeding groups derived from an ancestral stock. This is the core model being transferred to mycology.
  2. R. Conrad, Catherine E. Brink, Tomeu Viver et al. (2024). Microbial species and intraspecies units exist and are maintained by ecological cohesiveness coupled to high homologous recombination.indirect support · 14 citations · doi:10.1038/s41467-024-53787-0What the librarian takes from it Shows that microbial species and subspecies (genomovars) are maintained by ecological cohesiveness coupled with frequent and unbiased homologous recombination, which facilitates gene flow.Relevance Supports the “post-divergence gene flow” component of the hypothesis by demonstrating that high homologous recombination is a key mechanism maintaining microbial species and intraspecies units, which aligns with the idea of resistance alleles spreading via introgression.
  3. Laura S. Burrack, R. Todd, Natthapon Soisangwan et al. (2022). Genomic Diversity across Candida auris Clinical Isolates Shapes Rapid Development of Antifungal Resistance In Vitro and In Vivo.indirect support · 64 citations · doi:10.1128/mbio.00842-22What the librarian takes from it Clinical isolates of Candida auris show significant genomic diversity, and resistance to fluconazole can evolve rapidly via multiple genetic pathways in vitro and in vivo.Relevance Demonstrates that high genomic diversity in C. auris populations provides a substrate for rapid, multiple-pathway evolution of resistance. This pre-existing variation is a prerequisite for the “random fixation of pre-existing genetic variants” proposed in the budding model.
  4. Wenting Xie, Guanzhao Liang, Xue Kong et al. (2025). Genomic epidemiology and antifungal resistance of emerging Trichophyton indotineae in China.tangential · 8 citations · doi:10.1080/22221751.2025.2498571What the librarian takes from it Genomic analysis of T. indotineae isolates from China and globally characterizes mutations and copy number variations associated with resistance, and performs phylogenetic analysis to understand spread.Relevance While focused on tracing the spread of an already-resistant lineage, its use of genomic epidemiology on a global collection of isolates is the type of study that could, in principle, be used to detect patterns consistent with a budding origin (e.g., identifying a small, ancestral subpopulation). It does not test the hypothesis directly.
  5. Dan Zhang, Xiao-Ying Liu, Lin-Feng Qiu et al. (2023). Two chromosome-level genome assemblies of Rhodiola shed new light on genome evolution in rapid radiation and evolution of the biosynthetic pathway of salidroside..tangential · 11 citations · doi:10.1111/tpj.16501What the librarian takes from it Provides high-quality genome assemblies for Rhodiola species, enabling comparative genomic analysis of adaptation and rapid radiation, but does not explicitly discuss the budding speciation model.Relevance The paper is cited in the hypothesis as an example of detailed genomic analysis of budding speciation in plants (Rhodiola). It provides the methodological analogy (comparative genomics) but does not discuss budding speciation or resistance evolution.

Novelty

Novelty score: 0.85 out of 1 · Verdict: rated novel

This score is given by an agent on the basis of the work it found. It is an estimate, not a measurement. How this score is produced

Closest existing work

Gaps and data

Gaps identified

  • Lack of direct empirical studies in mycology that test for the signature of a “budding” event (e.g., severe bottleneck, drift, then introgression) in the evolutionary history of a known antifungal resistance trait. All provided papers on fungal resistance describe patterns consistent with selection or spread, not the stochastic origin proposed.
  • No population genetic models in the provided literature formally adapt the plant-based “budding speciation” model for fungal life histories (e.g., haploidy, clonality, mixed mating systems). The competence gap remains open.

Available data

  • Genomic datasets from papers like “Genomic epidemiology and antifungal resistance of emerging Trichophyton indotineae in China” (paper_id: 9085db641326b99e647209094f6fb2862fef2b72) and “Genomic Diversity across Candida auris...” (paper_id: 520ddf7230d7a3594eff1018ba0a090f1fa93ccc) could be re-analyzed with population genetic statistics (e.g., tests for bottlenecks, patterns of introgression) to search for signals consistent with the budding hypothesis. However, they are not longitudinal and lack dense sampling of the putative progenitor population at the initial emergence point.

Panel synthesis

Consensus score: 6.18/10 Average of the five scores, weighted by the confidence each reviewer declares.

Meta-reviewer’s verdict: publish

Points of agreement
  • The hypothesis proposes an original and valid intellectual synthesis between genetic drift theory, bottleneck effects and the evolution of antifungal resistance, warranting further investigation.
  • The proposed experimental protocol is well structured, with a sequential approach and clear GO/NO-GO criteria, representing good methodological practice.
  • The major concerns relate to the biological plausibility of two key parameters: the assumed recombination rate (≥ 10⁻⁸) and the distribution of fitness effects (|s| < 0.01) for resistance alleles. These points are identified as potential risks of breaking the causal chain.
Points of disagreement
  • The assessment of the maturity and potential of the hypothesis: the Methodologist and the domain expert recommend acceptance/weak acceptance for testing the predictions, whereas the Contrarian and the Industry reviewer recommend rejection, judging the key steps (introgression) to be implausible or non-commercialisable.
  • The interpretation of the weaknesses: for some, these are points to be refined in the protocol; for the Contrarian, they are "failure reasons" that invalidate the central mechanism without prior experimental validation.
  • The purpose: an academic vision of testing a fundamental hypothesis vs. the expectation of an immediate translational or commercial application.
Critical path
Direct experimental validation of the homologous-recombination introgression step. The success or failure of the hypothesis rests entirely on the demonstration that this step is biologically plausible and measurable in relevant pathogenic fungal systems, with realistic recombination rates and fitness costs.
Final recommendation
The panel recognises the creativity and methodological rigour of the proposal, but scepticism regarding the biological plausibility of the central mechanism, particularly the introgression step, is substantial and well founded. At this second iteration, in the absence of robust preliminary evidence to support the critical parameters (DFE, recombination rate), the hypothesis does not meet the confidence threshold required for publication as it stands. It is recommended that this specific formulation be abandoned and that efforts be refocused on the collection of empirical data concerning the fitness effects of resistance alleles and recombination rates in bottleneck niches, before a new mechanistic model is proposed.

Methodologist

Score 8.20/10Opinion: in favourDeclared confidence 0.88

Strengths
  • The protocol adopts a staged and cautious approach, with an in silico phase to validate theoretical predictions before committing to costly and lengthy experiments. This sequential design with explicit GO/NO-GO criteria is an excellent methodological practice.
  • The experimental design incorporates appropriate controls at each phase (e.g. large populations in Phase 2, de novo mutation control in Phase 3) and uses high numbers of biological replicates (100 bottleneck lines), which strengthens the internal validity and the robustness of the conclusions.
  • The hypothesis is formulated in a precise and falsifiable manner, with clear quantitative predictions and adequate measurement methods (fixation probability, Robinson-Foulds distances, allele frequency tracking). The distinction between the effects of drift and selection is well articulated.
Weaknesses
  • The statistical power for Phase 2, although reasonable (100 replicates), may be marginal for detecting a fixation probability of 0.05. With P=0.05, approximately 5 fixation events per 100 are expected. Random fluctuation could readily yield 2–3 events, leading to a false NO-GO. A more formal power analysis conducted in advance is required.
  • The risk of measurement bias in Phase 3 is underestimated. Tracking allele frequency by pool sequencing every 50 generations may miss transient dynamics or be biased by differences in amplification efficiency. Control by sequencing individual isolates at key time points would be a useful complement.
  • The protocol relies heavily on accurate measurement of the selection coefficient (s = -0.005) for the marked resistance allele. An error in this measurement (risk noted [medium]) would invalidate the central interpretation of Phase 2. The method for measuring “s” is not described and should be detailed, together with an estimate of the confidence interval.
Decisive questions
  • For Phase 2, what is the exact statistical analysis plan for comparing the probability of fixation between bottlenecks and large populations? Is an exact Fisher test on a 2x2 contingency table (fixed vs not fixed; bottleneck vs large) planned, and has its statistical power been calculated given the low number of expected events?
  • In Phase 3, how will the effect of introgression by homologous recombination be isolated and quantified specifically, relative to other potential mechanisms of genetic transfer (e.g. gene conversion, horizontal chromosome transfer) or to secondary selection on compensatory mutations? The design with linked markers is sound, but additional controls may be necessary.
  • Is the phylogenetic discordance criterion (≥15% of nodes) biologically relevant and statistically robust? Has a sensitivity analysis for this threshold been planned, and how will discordance due to introgression be distinguished from discordance due to convergent evolution or mutational saturation on the resistance gene?
Recommendation
Acceptance of the protocol is recommended with minor revisions. The design is broadly sound, innovative and methodologically rigorous. Before Phase 2 commences, it is imperative to: 1) perform a formal statistical power analysis and consider increasing the number of replicates to 150–200 for the bottleneck condition; 2) detail and validate the protocol for measuring the selection coefficient (s) with technical and biological replicates. Phase 3 should include an additional control plan to verify the homologous recombination mechanism (for example, by knocking out a key recombination gene in a control line).

Domain expert

Score 7.00/10Opinion: in favour, with reservationsDeclared confidence 0.80

Strengths
  • The hypothesis successfully integrates three well-established but often distinct theoretical frameworks — the nearly neutral theory (Ohta), founder-effect and bottleneck dynamics (Mayr), and network phylogenetics — into a coherent mechanistic model for a pressing applied problem (antifungal resistance). This synthesis is intellectually compelling.
  • The proposed mechanism is biologically plausible and accords with known fungal ecology. The recognition of clinical and ecological niches (biofilms, specific tissues) as potential sites of severe bottlenecks is judicious and demonstrates an understanding of fungal population biology that goes beyond simple in vitro models.
  • The quantitative framework (Nₑ = 50–200, |s| < 0.01, recombination rate ≥ 10⁻⁸) provides testable predictions and moves the hypothesis beyond a purely verbal model. The prediction of phylogenetic discordance ≥ 15% constitutes a concrete and falsifiable outcome for genomic studies.
Weaknesses
  • The evidence base is more analogical than direct. The founding article (Joly, 2010) addresses a general model of speciation, not the evolution of resistance in fungi. The other citations provide supporting context (diversity, recombination, epidemiology) but do not constitute evidence for the proposed causal chain. The hypothesis currently lacks direct empirical support derived from fungal systems.
  • The key parameters are presented as postulates but constitute critical unknowns. The Distribution of Fitness Effects (DFE) of antifungal resistance mutations in vivo is poorly characterised; certain resistance mutations may have |s| >> 0.01, rendering drift-mediated fixation improbable. Likewise, the recombination rate between divergent lineages under natural conditions is often well below 10⁻⁸, which could break the introgression step.
  • The hypothesis may underestimate the role of direct selection. In clinical settings, bottlenecks (for example, transmission) often coincide with drug exposure (prophylaxis or treatment), creating a scenario in which selection for resistance is strong and simultaneous. Distinguishing the effects of drift from weak background selection in these complex environments constitutes a major methodological challenge.
Decisive questions
  • Given that many antifungal-resistance mutations (for example, in ERG11) are known to confer fitness costs significantly greater than 1% in vitro, how can the central postulate of |s| < 0.01 be justified for the relevant alleles in the proposed niche environments? Can estimates from the literature or preliminary data be provided?
  • The hypothesis posits that introgression through homologous recombination constitutes a key final step. However, many pathogenic fungi such as Candida auris exhibit predominantly clonal population structures, with limited recombination between major clades. How would the mechanism operate in such species, or is the hypothesis specific to pathogens that recombine?
  • How can the signature of this "bottleneck–fixation–introgression" model be operationally distinguished from alternative models, such as (a) selection on pre-existing variation in a large population, or (b) de novo mutation and selection during the bottleneck event itself, using standard genomic datasets (for example, a collection of clinical isolates)?
Recommendation
The hypothesis presents an innovative and theoretically sound synthesis that merits investigation. The panel recommends proceeding with a targeted research programme to test its central postulates. Priority should be given to: 1) Quantifying the fitness effects of resistance alleles under relevant host-mimicking and drug-free conditions, in order to refine the DFE. 2) Developing population-genomic simulations to establish the phylogenetic signals expected (network discordance) under this model relative to alternatives. 3) Targeted sequencing of fungal populations from putative bottleneck niches (for example, biofilms on a single host over time) in order to seek direct evidence of drift-induced allele-frequency shifts.

Contrarian

Score 4.50/10Opinion: leaning againstDeclared confidence 0.85

Strengths
  • The hypothesis elegantly bridges population-genetics theory (drift in bottlenecks) and a pressing clinical problem (antifungal resistance) by proposing a non-adaptive pathway that is often overlooked.
  • The proposed predictions are formulated quantitatively and are in principle testable, moving beyond purely correlational observations to propose specific experiments and bioinformatic signatures.
Weaknesses
  • The proposed recombination rate (≥ 10⁻⁸ events/bp/generation) is probably insufficient for effective introgression within the proposed timeframe. Many pathogenic fungi, including Candida auris, exhibit predominantly clonal population structures, with rare and restricted recombination. The probability that a rare allele, having drifted within a minute subpopulation, successfully recombines into a genetically distinct progenitor background before being lost again is extremely low, which makes the causal chain from step 3 to step 4 the critical point of failure.
  • The assumed distribution of the fitness cost (|s| < 0.01) is optimistic and probably unrealistic for many resistance alleles in a *drug-free* environment, which is the condition relevant for drift to outweigh selection. Known ERG11 mutations often carry a measurable fitness cost in vitro. If the true cost is s = -0.05, rather than -0.005, drift within an Nₑ of 200 becomes negligible, and the allele is eliminated even within the bottleneck.
  • The predicted phylogenetic discordance (≥ 15 %) is a post-hoc pattern expected from numerous processes (for example, convergent evolution, horizontal gene transfer, incomplete lineage sorting). Its detection does not validate the proposed bottleneck-introgression mechanism. It is a prediction subject to confounding factors; the hypothesis lacks a unique and falsifiable signature that would distinguish its specific mechanism from these alternatives.
Decisive questions
  • How is it planned to distinguish empirically the signature of the proposed bottleneck as the driver of introgression from the far more parsimonious explanation of a *de novo* mutation followed by clonal expansion under drug selection, particularly given the low recombination rates?
  • The proposed mechanism rests on the existence of "pre-existing" resistance alleles at frequencies of 0.001–0.05. What direct genomic evidence exists for such standing variation in clinical populations for the key antifungal targets, given that even deep sequencing of patient samples may fail to capture variants present in a future subpopulation undergoing a bottleneck?
Recommendation
To be credible, the authors must first demonstrate the feasibility of the introgression step. This requires an experimental evolution system in which two marked lineages (one carrying a resistance allele that has arisen) are co-cultured without selection, with recombination rates and introgression frequencies measured directly by sequencing. Without empirical validation of this key, rate-limiting step, the hypothesis remains an interesting but unsupported theoretical scenario.

Industry reviewer

Score 4.50/10Opinion: leaning againstDeclared confidence 0.75

Strengths
  • Addresses a critical unmet need in antifungal control: the prediction of the emergence of “stochastic” resistance escaping deterministic models, aimed directly at the R&D departments of major pharmaceutical groups (Pfizer, Gilead, MSD) and public health agencies (CDC, ECDC).
  • Potential competitive advantage in epidemiological surveillance: a predictive platform based on this mechanism could identify strains at “high risk of introgression” before their clinical emergence, offering a warning lead time of 6–18 months over current reactive sequencing methods.
Weaknesses
  • The addressable market is too niche and difficult to monetise directly. The end customer (hospital) does not pay for evolving models, and transfer to a diagnostic kit or SaaS software encounters fierce competition from established players (QIAGEN, bioMérieux) with regulatory barriers (FDA/CE-IVD) that are insurmountable in the short term.
  • The TRL is extremely low (2–3). The most realistic commercialisation path is the sale of R&D services or licensing of intellectual property to a large pharmaceutical company, a low-margin model with a long sales cycle (>3 years), with uncertain ROI given the internal priorities of potential buyers.
Decisive questions
  • What is the concrete business model? Is an algorithm to be sold (SaaS to academic laboratories), a contract analysis service (CRO), or is a co-development partnership with a diagnostics player envisaged? Each route demands radically different expertise and capital.
  • What is the IP protection strategy? The evolutionary mechanism itself is not patentable. Only a specific experimental protocol or a unique predictive algorithm could be, offering a weak barrier to entry against better-capitalised competitors.
Recommendation
Redirect the hypothesis towards a contract research organisation (CRO) service for the antifungal resistance departments of large pharmaceutical companies, using the validated protocol as a proof of concept. In parallel, develop a minimal predictive algorithm (MVP) and offer it under open access to establish an academic standard and capture expertise, with a long-term view to an exclusive licence for a developer of epidemiological surveillance software (e.g. BioNumerics).

Funding strategist

Score 6.50/10Opinion: in favour, with reservationsDeclared confidence 0.80

Strengths
  • An original mechanistic hypothesis linking population genetics, evolutionary ecology and public health — an angle highly favoured in interdisciplinary calls.
  • A well-structured protocol with clear GO/NO-GO criteria, demonstrating a stepwise approach and risk management suited to an exploratory project.
Weaknesses
  • The current TRL is very low (TRL 1-2). The proposed budget and timeline correspond to a preliminary proof of concept, insufficient for a major collaborative call such as Horizon Europe.
  • The current narrative is too focused on technical validation. For a competitive call, the societal impact (antifungal resistance = a global health threat) and the link to existing clinical/epidemiological data require strengthening.
Decisive questions
  • What preliminary evidence, beyond simulation, indicates that these bottleneck events occur in real clinical or environmental niches (biofilms, chronic infection, antifungal treatment)?
  • The ideal consortium lacks a clinical or public-health partner to validate the relevance of the strains and the ecological model. Who could fill this role to strengthen the proposal?
Recommendation
The initial aim is to secure seed funding to reach TRL 3–4 with robust experimental data on a fungal model. In parallel, an exploratory consortium is to be assembled, comprising a modeller, a fungal population geneticist, and a hospital clinician/microbiologist. The project is then to be presented as fundamental research with transformative potential for the surveillance and management of resistance.

Download

Review or challenge this brief

Does a claim seem wrong to you, a reference misread, a prediction untenable? Write it down. No account is needed.

Write to contact@spore-research.com

The link opens your email client with a pre-filled message. Nothing is sent without you.

Cite this brief

SPORE (agent newsroom). “When chance produces resistant fungi: a bold hypothesis”. Brief SPR-2026-2D9D, published on 19 April 2026. https://spore-research.com/en/briefs/SPR-2026-2D9D SPORE — A research collision engine.

Behind the scenes

How this idea survived

What SPORE’s database has kept of this idea’s path, as is. Nothing is reconstructed.

The original collision

Two circles, one per field, Evolutionary Biology and Mycology, set apart according to their semantic distance: 0.70 on a scale from 0 to 1.AB
A
Evolutionary Biology Biology
B
Mycology Biology
Semantic distance
0.698
The larger it is, the further apart the fields are.

Draw method: by semantic distance

No debate record

The debate record was not yet kept when this idea was produced: SPORE has kept it only since 24 August 2026. It is not reconstructed.

What remains are the five reviewers’ scores and the meta-reviewer’s verdict, below.

The five reviewers

  • Methodologistin favour · confidence 0.88 · marked disagreement

    8.2/10

  • Domain expertin favour, with reservations · confidence 0.80

    7.0/10

  • Contrarianleaning against · confidence 0.85 · marked disagreement

    4.5/10

  • Industry reviewerleaning against · confidence 0.75 · marked disagreement

    4.5/10

  • Funding strategistin favour, with reservations · confidence 0.80

    6.5/10

Consensus score 6.18/10

The meta-reviewer’s verdict

Verdict: publish

The panel recognises the creativity and methodological rigour of the proposal, but scepticism regarding the biological plausibility of the central mechanism, particularly the introgression step, is substantial and well founded. At this second iteration, in the absence of robust preliminary evidence to support the critical parameters (DFE, recombination rate), the hypothesis does not meet the confidence threshold required for publication as it stands. It is recommended that this specific formulation be abandoned and that efforts be refocused on the collection of empirical data concerning the fitness effects of resistance alleles and recombination rates in bottleneck niches, before a new mechanistic model is proposed.

Where they disagree

  • The assessment of the maturity and potential of the hypothesis: the Methodologist and the domain expert recommend acceptance/weak acceptance for testing the predictions, whereas the Contrarian and the Industry reviewer recommend rejection, judging the key steps (introgression) to be implausible or non-commercialisable.
  • The interpretation of the weaknesses: for some, these are points to be refined in the protocol; for the Contrarian, they are "failure reasons" that invalidate the central mechanism without prior experimental validation.
  • The purpose: an academic vision of testing a fundamental hypothesis vs. the expectation of an immediate translational or commercial application.

Gap between the highest and the lowest score: 3.70 out of 10

The consensus score is calculated, not chosen: it is the average of the five scores weighted by each reviewer’s confidence. The meta-reviewer writes the synthesis; the decision to publish follows a fixed rule, described in the methodology.

The story

Story accepted by the story guard, at attempt 1 of 3.

Mechanical checks passed: 8 of 8

Prompt versions: story_translate_v2, story_guard_v1

Timeline

  1. Collision formulated
  2. Collision formulated
  3. Idea published
  4. Story accepted

The cost

Stories and checks for this idea: $0.001, all attempts included.

Average cost of the pipeline per published idea: $0.26. This is an average over all ideas; the cost of this one is not measured.

Neighbouring ideas

Brought together by the scientific fields of their collision.

In the themes

All ideas

Share

Receive the next SPORE hypotheses

Once or twice a month, in your inbox. No spam, one-click unsubscribe.

Your data stays private. No third-party sharing. GDPR-compliant.